As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray
Texas Oncology Designated Aranesp As Preferred Treatment
After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk
Foundation Gives $1 Million To UPCI For Genetics Chair
Funding Opportunities
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation